<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211219053454N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-01-04</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of subzero balanced –modified ultrafiltration technique on chemical and clinical outcomes in cardiopulmonary bypass of pediatrics undergoing cardiac surgery</public_title>
      <acronym></acronym>
      <scientific_title>The effect of subzero balanced –modified ultrafiltration technique on chemical and clinical outcomes in cardiopulmonary bypass of pediatrics undergoing cardiac surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60783</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: To randomly assign samples to each group, a random list obtained from a random number table by permutation block method is used.
After receiving the patient in the operating room, his / her characteristics and tests are checked. If he / she meets the conditions for admission to the study, he / she will be assigned to one of the intervention or control groups according to the table of random numbers received from randomization.com, Blinding description: Due to the nature of the study, children undergo surgery are not and will not be aware of the techniques performed during operation. Also, ICU nurses who record most of the information assessed after surgery are not aware of the process and techniques performed in the operating room.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Ventricular septal defect. Condition 2: Congenital heart disease. Condition 3: Tetralogy of Fallot.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Children undergoing heart surgery who receive a sub-zero ultrafiltration technique continuously during the bypass, and after the cardiac bypass is completed, the modified ultrafiltration technique will be performed on them for about 10 minutes. Intervention 2: Control group: Children undergoing heart surgery who undergo the conventional ultrafiltration technique when needed and at the discretion of the perfusionist.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic informations

When:
Start of access period from 1402

To whom:
People working and researching in the field of cardiovascular surgery

Conditions:
All analyzes are allowed

Where to obtain:
Mr. Mehrtash Shadmehr +989366875622 Mehrtash.shad@yahoo.com

How to obtain:
Send email and coordinate

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Khalil Zarrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zand st</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7134846114</zip>
        <telephone>+98 71 3235 1088</telephone>
        <email>Zarrabisx@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Khalil Zarrabi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Zand st</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7134846114</zip>
        <telephone>+98 71 3235 1090</telephone>
        <email>Zarrabisx@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>weight between 3 to 30 Kg
No renal dysfanction
being born term
normal blood potassium
No transfusions of blood and its products prior to operation
age between 0 to 18</inclusion_criteria>
      <agemin>1 month</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>weight under 3 and above 3 kg
renal dysfunction
being born preterm
abnormal potassium
transfusion of blood and its products
age above 18
administered diuretic prior to operation</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Q21.0</hc_code>
      <hc_code>Q24.9</hc_code>
      <hc_code>Q21.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Ventricular septal defect</hc_keyword>
      <hc_keyword>Congenital malformation of heart, unspecified</hc_keyword>
      <hc_keyword>Tetralogy of Fallot</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Children undergoing heart surgery who receive a sub-zero ultrafiltration technique continuously during the bypass, and after the cardiac bypass is completed, the modified ultrafiltration technique will be performed on them for about 10 minutes.</i_keyword>
      <i_keyword>Control group: Children undergoing heart surgery who undergo the conventional ultrafiltration technique when needed and at the discretion of the perfusionist</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Changes in blood potassium during bypass. Timepoint: Measuring the amount of potassium before the bypass and at half-hour intervals during bypass until its end. Method of measurement: Potassium testing is performed with an ABG measuring device in the cardiac operating room.</prim_outcome>
      <prim_outcome>Measuring the amount of blood / products after operation. Timepoint: Daily. Method of measurement: Blood and products are in graduated  bags that the amount injected is recorded by the ICU nurse.</prim_outcome>
      <prim_outcome>Measurement of urinary output after surgery. Timepoint: Daily. Method of measurement: Urine is emptied into graduated containers, which are recorded by the ICU nurse on an hourly basis. We calculate the average daily urine output per person.</prim_outcome>
      <prim_outcome>Evaluation the incidence of cardiac dysrhythmia. Timepoint: Constantly. Method of measurement: By ECG monitoring. In case of occurrence, it will be recorded.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>ICU length of stay. Timepoint: Daily. Method of measurement: The patient entering and leaving the ICU is recorded.</sec_outcome>
      <sec_outcome>Evaluating the GFR during ICU stay. Timepoint: Daily. Method of measurement: GFR determination is calculated by the formula (Schwartz) which has a specific coefficient according to age, height, sex and creatinine.</sec_outcome>
      <sec_outcome>Measurement of blood transfusion during surgery. Timepoint: Hourly during surgery. Method of measurement: The blood is in graduated bags where the amount transfused is recorded.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-11-16</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Zand st. Namazi sq. Shiraz Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
